Kalyra Pharmaceuticals, Inc.
Novel ERK inhibitor molecules targeting KRAS-mutant pancreatic cancer
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Founded
- 2012
- Latest Form D
- $5.2M, Aug 2013
- Total capital
- $8.3M
- Federal grants
- $3.2M
- 6 awards · 2015–2018
- Rank in peer group#311 of 514
- Private capital raised
- $5.2M
- 1 Form D · last Aug 2013
- 158 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 31 pending · first 2016
- Rank in peer group#40 of 514
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma$79K
- Federal grantHealth and Human S · Phase II · A new class of non-opioid analgesics for use in chronic pain management$95K
- Federal grantHealth and Human S · Phase II · Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma$298K
- Federal grantHealth and Human S · Phase II · A new class of non-opioid analgesics for use in chronic pain management$1.1M
- Federal grantHealth and Human S · Phase I · A New Treatment to Reduce Scarring$306K
- Federal grantHealth and Human S · Phase II · A new class of non-opioid analgesics for use in chronic pain management$1.2M
- Private capital raisedForm D · SEC · 1st filing$5.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#40 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Kevin D. BunkerResearcherExecutive Officer, DirectorLinked by $2.5M in grants as PI
- Cam L. GallagherExecutive OfficerNamed in SEC Form D filings
- Cam L. GarnerDirectorNamed in SEC Form D filings
- Dirk A. ThyeDirectorNamed in SEC Form D filings
- Michael E. BreedeDirectorNamed in SEC Form D filings
- Ned A. IsraelsenExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
- Scott L. GlennDirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 39- GrantedPropellane Derivates And SynthesisUSPTOUS 10,654,812
- GrantedBicyclic CompoundsUSPTOUS 10,308,609
- GrantedBicyclic Analgesic CompoundsUSPTOUS 10,251,851
Show all 39 patent records
- Propellane Derivates And SynthesisMay 19, 2020 · US 10,654,812Granted
- Bicyclic CompoundsJun 4, 2019 · US 10,308,609Granted
- Bicyclic Analgesic CompoundsApr 9, 2019 · US 10,251,851Granted
- Bicyclic Alkyl Compounds And SynthesisJan 29, 2019 · US 10,189,780Granted
- Bicyclic CompoundsJul 19, 2018 · Application 15572744Pending
- Bicyclic Analgesic CompoundsAug 8, 2017 · US 9,724,316Granted
- Bicyclic Analgesic CompoundsJul 4, 2017 · US 9,693,975Granted
- Bicyclic Analgesic CompoundsSep 20, 2016 · US 9,447,025Granted
- Bicyclic Analgesic CompoundsSep 20, 2016 · US 9,447,026Granted
- Methods For Cross CouplingApplication 62378453Pending
- Egfr Inhibitor CompoundsApplication 62342141Pending
- Bicyclic CompoundsApplication PCTUS2016031663Pending
- Estrogen Receptor ModulatorsApplication 62317254Pending
- Spirocyclic CompoundsApplication PCTUS2016025345Pending
- Analgesic CompoundsApplication 62309342Pending
- Analgesic CompoundsApplication 62309338Pending
- Analgesic CompoundsApplication 62309355Pending
- Analgesic CompoundsApplication 62309371Pending
- Antifungal Compounds And MethodsApplication 62264497Pending
- Bicyclic CompoundsApplication PCTUS2015050275Pending
- Bicyclic CompoundsApplication 62160413Pending
- Spirocyclic CompoundsApplication 62142946Pending
- Propellane Derivates And SynthesisApplication PCTUS2015018886Pending
- Bicyclic Alkyl Compounds And SynthesisApplication PCTUS2014069517Pending
- Bicyclic CompoundsApplication 62051760Pending
- Bicyclic Alkyl Compounds And SynthesisApplication 61949619Pending
- Propellane Derivates And SynthesisApplication 61949733Pending
- Bicyclic Analgesic CompoundsApplication PCTUS2014021038Pending
- Bicyclic Alkyl Compounds And SynthesisApplication 61915415Pending
- Benzamide CompoundsApplication 62615857Pending
- Bicyclic Analgesic CompoundsApplication 61781580Pending
- Spirocyclic CompoundsApplication PCTUS2017054865Pending
- Continuous Flow Processes For Making Bicyclic CompoundsApplication 62556897Pending
- 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE AnalogsApplication 62539734Pending
- Acrylic Acid AnalogsApplication 62538486Pending
- Analgesic CompoundsApplication 62506512Pending
- Antifungal Compounds And MethodsApplication PCTUS2016065097Pending
- Antifungal Compounds And MethodsApplication 62430534Pending
- Spirocyclic CompoundsApplication 62404668Pending
Related companies, and why
- CAPRICOR, INC.Similar federal contract value in Biotech · null in contracts
- ONCOTRAP INCSimilar federal contract value in Biotech · null in contracts
- PolyCore Therapeutics LLC.Similar federal contract value in Biotech · null in contracts
- SITEONE THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- ALECTOR, LLCSimilar federal contract value in Biotech · null in contracts
- EPIODYNE, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .